Other payable - equipment purchase (1,241,003) --
Other payable - discount on
equipment purchase 626,370 --
Other payable - Intercompany -- --
Customer deposit 297,543 1,128,506
Taxes payable 2,261,984 316,605
Net cash provided by
operating activities 12,700,902 5,939,428
CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisition of equity investment -- (904,043)
Purchases of plant and equipment (154,262) (497,603)
Proceeds from equipment disposal 35,266 --
Additions to construction in
progress (7,725,153) (11,697,698)
Acquisition of land use right (324,031) (10,747)
Purchase of software program (5,426) --
Advances on plant and equipment purchase (9,876,385) (1,069,809)
Loan repayment from related party 678,200 --
Proceed from land use right disposal 30,826 --
Net cash used in
investing activities (17,340,965) (14,179,900)
CASH FLOWS FROM FINANCING
ACTIVITIES:
Decrease (increase) in restricted cash 3,407,360 (1,518,640)
Borrowings on notes payable - banks 5,425,600 12,959,405
Payments on notes payable - banks (10,579,920) (11,431,445)
Borrowings on short term loans 12,750,160 17,100,419
Payments on short term loans (11,380,196) (7,550,669)
Borrowings on employee loans
'/>"/>
| SOURCE Shengtai Pharmaceutical, Inc. Copyright©2008 PR Newswire. All rights reserved |